Navigation Links
Describe your invention, or your biotech patent may be worthless

The U.S. Supreme Court made a patent-law decision on Monday that could have multibillion-dollar ramifications for patent holders in the biotechnology sector.

The court denied an appeal in Univ. of Rochester v. G.D. Searle & Co. This effectively solidifies the decision that was made by the U.S. Court of Appeals for the Federal Circuit, which invalidate......

Full article >>> ned to be significant in the production and discovery of non-steroidal and anti-inflammatory drugs.

The University of Rochester ultimately received a patent (6,048,850) which covered methods for selectively inhibiting PGHS-2 activity in a human host, comprising administering a nonsteroidal compound that selectively inhibits activity of the PGHS-2 gene product to a human host in need of su......

Full article >>> med invention.

In the case of Noelle v. Lederman, the Federal Circuit decided that a patent for an antibody need not provide a written description of the antibody. However, provided that an application discloses a fully characterized antigen, the application may properly claim an antibody by its binding affinity to that described antigen. At first glance, this may appear to contra......

Full article >>> ication that fulfills the statutory requirements. An inventor may add additional description to the application, but it must then be filed as a separate child application. The problem with this procedure is that the new matter added would have a priority date of the child application and not of the parent.

For biotechnology related inventions a matter of days can translate into considerab......

Full article >>> those of the author, & do not necessarily reflect the views of The Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or responsibility for any claims made or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Jonathan Fritz 12/01/04


Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Getting noticed in Genetown: Wisconsin biotech on display
4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
5. Wisconsin biotech firm receives $107K NIH grant
6. Manufacturing partnership will move into biotech and biomedical spaces
7. Wisconsin wont get Georgia biotech without a fight
8. The 10 biggest events shaping biotech in 2006
9. NimbleGen partners with UK biotech firm
10. 2006: A great biotech financing year, unless you were going public!
11. Big pharma seeks Wisconsin biotech partnerships
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... Minn. , Feb. 23, 2017  Imanis ... new product line of oncolytic vaccinia viruses for ... Corporation as part of Genelux,s proprietary, vaccinia virus-based ... are excited to enter into a partnership with ... selected oncolytic vaccinia viruses for use in research," ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can fast-track ... uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect saliva ... , the relationship between insulin and other relevant biomarkers can be extensively studied ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 /PRNewswire/ ... and Beyond Type 1, a not-for-profit advocacy and education ... announced a grant from Beyond Type 1 to support ... 1 and other insulin-requiring diabetes.  For ... stem cell-derived cell replacement therapies with a focus on ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
Breaking Biology Technology:
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market Intelligence ... Biometrics and Digital Identity".  Acuity characterizes 2017 as ... when increased adoption reflects a new understanding of ... "Biometrics and digital identity are often perceived ... Maxine Most , Principal of Acuity Market intelligence. ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm ... of the laboratory use of nuclear magnetic resonance ... experienced end-users and profiled current practices, developments, trends ... as well as growth and opportunities. These areas ... suppliers, NMR instruments, needs and innovation requirements, hyphenated ...
Breaking Biology News(10 mins):